Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06348069
Status:
RECRUITING
Last Update Posted:
2024-04-04
First Post:
2024-03-29
Brief Title:
Pharmacy-based PrEP for Young Women Who Sell Sex in Zimbabwe
Sponsor:
University of California Berkeley
Organization:
University of California Berkeley
Study Overview
Official Title:
Pharmacy-based PrEP for Young Women Who Sell Sex in Zimbabwe
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TOPAZ
Brief Summary:
Pharmacy-based PrEP for Young Women who Sell Sex in Zimbabwe is a cluster-randomized control trial and pilot study co-led by Dr Euphemia Sibanda Reader Associate Professor of Global Health and Epidemiology at Liverpool School of Tropical Medicine UK and Research Director at the Centre for Sexual Health and HIV Research CeSHHAR Zimbabwe and Dr Sandra McCoy Professor of Epidemiology and Biostatistics at the University of California Berkeley The goal of the proposed study is to optimize refine and pilot a pharmacy-based PrEP intervention for female sex workers FSW in Zimbabwe Despite efforts to reach the most impacted and vulnerable populations with PrEP retention rates particularly among FSW in Africa are very low Relatively high levels of uptake indicate that FSW are interested in PrEP and ready to initiate it but in most cases fewer than 50 of those who initiate return for medication refills by month 4 Pharmacy-based PrEP has the potential to address known barriers to PrEP retention among FSW such as stigma and access and coupled with a small escalating incentive in the form of a gift card incentive could also boost motivation for effective use of PrEP
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None